Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 393281 - 393300 out of 563611 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Norway | (L01EX08) lenvatinib | Kisplyx 10 mg | 30 stk, Blisterpakning, Kapsel, hard, 10 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | OrifarmAS |
| Norway | (L01EX08) lenvatinib | Lenvima 10 mg | 30 stk, Blisterpakning, Kapsel, hard, 10 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | EisaiGmbH |
| Norway | (L01EX08) lenvatinib | Kisplyx 4 mg | 30 stk, Blisterpakning, Kapsel, hard, 4 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | OrifarmAS |
| Norway | (L01EX08) lenvatinib | Kisplyx 4 mg | 30 stk, Blisterpakning, Kapsel, hard, 4 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | EisaiGmbH |
| Norway | (L01EX08) lenvatinib | Lenvima 4 mg | 30 stk, Blisterpakning, Kapsel, hard, 4 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | EisaiGmbH |
| Norway | (L01EX08) lenvatinib | Lenvima 4 mg | 30 stk, Blisterpakning, Kapsel, hard, 4 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | OrifarmAS |
| Norway | (L01EX12) larotrectinib | Vitrakvi 20 mg/ml | 1 x 100 ml, Flaske av glass, Mikstur, oppløsning, 20 mg/ml , Flaske av glass | Retail price with vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerAG |
| Norway | (L01EX12) larotrectinib | Vitrakvi 20 mg/ml | 2 x 50 ml, Flaske av glass, Mikstur, oppløsning, 20 mg/ml , Flaske av glass | Retail price with vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerAG |
| Norway | (L01EX12) larotrectinib | Vitrakvi 20 mg/ml | 1 x 100 ml, Flaske av glass, Mikstur, oppløsning, 20 mg/ml , Flaske av glass | Retail price with vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | OrifarmAS |
| Norway | (L01EX12) larotrectinib | Vitrakvi 100 mg | 56 stk, Boks, Kapsel, hard, 100 mg , Boks | Retail price with vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerAG |
| Norway | (L01EX12) larotrectinib | Vitrakvi 25 mg | 56 stk, Boks, Kapsel, hard, 25 mg , Boks | Retail price with vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerAG |
| Norway | (L01EX13) gilteritinib | Xospata 40 mg | 84 stk, Blisterpakning, Tablett, filmdrasjert, 40 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute | AstellasPharmaEuropeB.V.-Leiden |
| Norway | (L01EX14) entrectinib | Rozlytrek 100 mg | 30 stk, Boks, Kapsel, hard, 100 mg , Boks | Retail price with vat |
$0-0 |
$0-0 |
Cancer; Carcinoma, Non-Small-Cell Lung | RocheRegistrationGmbH |
| Norway | (L01EX14) entrectinib | Rozlytrek 200 mg | 90 stk, Boks, Kapsel, hard, 200 mg , Boks | Retail price with vat |
$0-0 |
$0-0 |
Cancer; Carcinoma, Non-Small-Cell Lung | OrifarmAS |
| Norway | (L01EX14) entrectinib | Rozlytrek 200 mg | 90 stk, Boks, Kapsel, hard, 200 mg , Boks | Retail price with vat |
$0-0 |
$0-0 |
Cancer; Carcinoma, Non-Small-Cell Lung | RocheRegistrationGmbH |
| Norway | (L01FD01) trastuzumab | Herzuma 150 mg | 150 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 150 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | CelltrionHealthcareHungaryKft.(1) |
| Norway | (L01FD01) trastuzumab | Kanjinti 150 mg | 1 x 150 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 150 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | AmgenEuropeB.V.(2) |
| Norway | (L01FD01) trastuzumab | Ontruzant 150 mg | 150 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 150 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | SamsungBioepisNLB.V. |
| Norway | (L01FD01) trastuzumab | Herzuma 420 mg | 420 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 420 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | CelltrionHealthcareHungaryKft.(1) |
| Norway | (L01FD01) trastuzumab | Kanjinti 420 mg | 1 x 420 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 420 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | AmgenEuropeB.V.(2) |
Pages
